NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Miist Therapeutics

Miist Therapeutics

Private
Alameda, CaliforniaHealthcare & Life Scienceshttps://www.miisttherapeutics.com/

Last Round

Seed

Feb 5, 2025

Total Funding Raised

$7M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Miist Therapeutics is a biotechnology company that develops inhaled therapies designed for rapid symptom relief using proprietary aerosol physics technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

inhaled drug deliveryvibrating mesh nebulizerdrug-device combinationnebulizerpulmonary drug deliveryacute caresmoking cessationmigraine therapyaerosol therapybiotechclinical-stage biotechdrug delivery platformmedtechpharmaceutical developmentdrug licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Miist Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Miist Therapeutics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Miist Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 5, 2025
View all Funding Rounds

Key People

Founding team and executive leadership

Dalton Signor

Founder And CEO

Founding Team

Miist Therapeutics Investors

Notable investors and investment history

Miist Therapeutics investors
InvestorRounds
Refactor CapitalSeed
1517 FundSeed
California Innovation FundSeed
Freeflow VenturesSeed
Freeflow VenturesSeed
Entrepreneurs FirstSeed
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 20, 2026

    Monthly visitors grew 430% MoM.

  • Feb 5, 2025

    $7M round completed.

View all signals

Miist Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Miist Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Miist Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersAlameda, California
Employee Range6
Year Founded2022
Last FundingFeb 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.